Efanov M, Granov D, Alikhanov R, Rutkin I, Tsvirkun V, Kazakov I, Vankovich A, Koroleva A, Kovalenko D
Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Research Center Named After Loginov A.S., shosse Entuziastov, 86, Moscow, Russia, 11123.
Russian Research Center of Radiology and Surgical Technologies Named After Granov A.M., Leningradskaya Str, 70, Pesochny, St. Peterburg, Russia, 197758.
Surg Endosc. 2021 Jan;35(1):96-103. doi: 10.1007/s00464-019-07363-z. Epub 2020 Jan 13.
Laparoscopic liver resection (LLR) of posterosuperior segments (PSS) is still technically demanding procedure for highly selective patients. There is no long-term survival comparative estimation after LLR and open liver resection (OLR) for colorectal liver metastases (CRLM) located in PSS. We aimed to compare long-term overall (OS) and disease-free survival (DFS) after parenchyma-sparing LLR with expanding indications and open liver resection (OLR) of liver PSS in patients with CRLM.
Two Russian centers took part in the study. Patients with missing data, hemihepatectomy and extrahepatic tumors were excluded. One of contraindications for LLR was suspicion for tumor invasion in large hepatic vessels. Logistic regression was used for 1:1 propensity score matching (PSM).
PSS were resected in 77 patients, which accounted for 42% of the total number of liver resections for CRLM. LLR were performed in 51 (66%) patients. Before and after matching, no differences were found between groups in the following factors: median size of the largest metastatic tumor; proximity to the large liver vessels; the rate of anatomical parenchyma sparing resection of PSS; a positive response to chemotherapy before and after surgery. Regardless of matching, the size of the largest metastases was above 50 mm in more than one-third of patients who received LLR. Before matching, intraoperative blood loss, ICU stay and hospital stay were significantly greater in the group of OLR. No 90-day mortality was observed within both groups. There were no differences in long-term oncological outcomes: 5-year OS after PSM was 78% and 63% after LLR and OLR, respectively; 4-year DFS after PSM was 27% in both groups.
Laparoscopic parenchyma-sparing resection of PSS for CRLM are justified in majority of patients who have an indication for OLR if performed in high volume specialized centers expertized in laparoscopic liver surgery.
对于高度选择性的患者,腹腔镜下肝后上段(PSS)切除术在技术上仍然具有挑战性。目前尚无关于位于PSS的结直肠癌肝转移(CRLM)患者接受腹腔镜肝切除术(LLR)和开腹肝切除术(OLR)后的长期生存比较评估。我们旨在比较采用扩大适应证的保留肝实质LLR与开腹肝PSS切除术治疗CRLM患者后的长期总生存(OS)和无病生存(DFS)情况。
两个俄罗斯中心参与了本研究。排除数据缺失、半肝切除术和肝外肿瘤患者。LLR的禁忌证之一是怀疑肿瘤侵犯大的肝血管。采用逻辑回归进行1:1倾向评分匹配(PSM)。
77例患者接受了PSS切除,占CRLM肝切除术总数的42%。51例(66%)患者接受了LLR。匹配前后,两组在以下因素方面无差异:最大转移瘤的中位大小;与大肝血管的距离;PSS解剖性保留肝实质切除术的比例;手术前后对化疗的反应。无论是否匹配,接受LLR的患者中超过三分之一的最大转移瘤大小超过50mm。匹配前,OLR组的术中失血量、ICU住院时间和住院时间显著更长。两组均未观察到90天死亡率。长期肿瘤学结局无差异:PSM后5年OS在LLR组和OLR组分别为78%和63%;PSM后4年DFS在两组均为27%。
对于大多数有OLR适应证的CRLM患者,如果在高容量、擅长腹腔镜肝脏手术的专业中心进行,腹腔镜保留肝实质PSS切除术是合理的。